AMMEDICS, a Korean biomaterials company, participated in ‘AMWC 2023’ held in Monaco from March 30th to April 1st and introduced AMMEDICS’s skin booster filler and lipolysis products to the global market.

AMWC (The Aesthetic and Anti-Aging Medicine World Congress) is the world's largest aesthetic and anti-aging medicine academic conference, visited by more than 10,000 people every year. Major companies in the aesthetic and anti-aging medicine fields from around 120 countries participated in the recently held AMWC 2023.

Among them, AMMEDICS, a Korean specialist in biomaterials, operated their independent booth at this event to promote biomaterial AQUA SEAL Skin Booster Filler and FILLSYS Dermal Filler.

Among AMMEDICS' products exhibited at AMWC, 'AQUA SEAL Skin Booster Filler' uses biomaterials peptide as an ingredient, which is known to be effective in preventing skin aging as well as whitening and moisturizing the skin. 

In recent times, products using biomaterials have been in the spotlight in the fields of aesthetics and anti-aging medicine, AMMEDICS's AQUA SEAL Skin Booster Filler received a lot of attention from visitors.

An AMMEDICS representative said about the filler products exhibited this time, “The filler products we produce are characterized by excellent stability by utilizing our cross-linking method. Since it is directly injected into our human body, we try to remove as much toxicity as possible from the raw materials themselves, even if it takes a long time,” he explained.

A Korean biomaterials company AMMEDICS established in 2019, researches and develops biomaterial peptides through biotechnology-based R&D and applies them to manufacture medical devices and cosmetics. AMMEDICS has considered overseas markets from the product development stage and is now participating in various exhibitions and forums to form a global network and meet business partners around the world.